Wood, P., Desai, J., Waldeck, K., Cain, J., Gottardo, N., Strong, R., … Ashley, D. (2022). A PHASE II STUDY OF CONTINUOUS LOW DOSE PANOBINOSTAT IN PAEDIATRIC PATIENTS WITH MALIGNANT RHABDOID TUMOURS AND ATYPICAL TERATOID RHABDOID TUMOURS. In NEURO-ONCOLOGY (Vol. 24, pp. 6–7).

Wood, Paul, Jayesh Desai, Kelly Waldeck, Jason Cain, Nicholas Gottardo, Robyn Strong, Kathryn Kinross, et al. “A PHASE II STUDY OF CONTINUOUS LOW DOSE PANOBINOSTAT IN PAEDIATRIC PATIENTS WITH MALIGNANT RHABDOID TUMOURS AND ATYPICAL TERATOID RHABDOID TUMOURS.” In NEURO-ONCOLOGY, 24:6–7, 2022.

Wood P, Desai J, Waldeck K, Cain J, Gottardo N, Strong R, et al. A PHASE II STUDY OF CONTINUOUS LOW DOSE PANOBINOSTAT IN PAEDIATRIC PATIENTS WITH MALIGNANT RHABDOID TUMOURS AND ATYPICAL TERATOID RHABDOID TUMOURS. In: NEURO-ONCOLOGY. 2022. p. 6–7.

Wood, Paul, et al. “A PHASE II STUDY OF CONTINUOUS LOW DOSE PANOBINOSTAT IN PAEDIATRIC PATIENTS WITH MALIGNANT RHABDOID TUMOURS AND ATYPICAL TERATOID RHABDOID TUMOURS.” NEURO-ONCOLOGY, vol. 24, 2022, pp. 6–7.

Wood P, Desai J, Waldeck K, Cain J, Gottardo N, Strong R, Kinross K, Carr M, Jones J, Wong L, Ziegler D, Hansford J, Michael M, Ashley D. A PHASE II STUDY OF CONTINUOUS LOW DOSE PANOBINOSTAT IN PAEDIATRIC PATIENTS WITH MALIGNANT RHABDOID TUMOURS AND ATYPICAL TERATOID RHABDOID TUMOURS. NEURO-ONCOLOGY. 2022. p. 6–7.